期刊
CANCER BIOLOGY & THERAPY
卷 6, 期 7, 页码 1015-1017出版社
LANDES BIOSCIENCE
DOI: 10.4161/cbt.6.7.4338
关键词
Ecteinascidin-743 (Yondelis); rhabdomyolysis; sarcoma
类别
Rhabdomyolysis is a clinical syndrome in which skeletal muscle damage and necrosis leads to the release of intracellular muscle contents, which can ultimately lead to electrolyte disturbances, renal failure and even death. Chemotherapy is an extremely rare cause of rhabdomyolysis. Herein, we describe a fatal case of rhabdomyolysis in a patient with metastatic sarcoma after receiving the chemotherapeutic agent Ecteinascidin-743 (ET-743, trabectedin) as palliative chemotherapy treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据